JOHANNA BAKER: Open Payments
NPI 1336575174 · MARIETTA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$943 in 59 payments from 11 companies in 2025. Trend: 2023 $1,076 · 2024 $408 · 2025 $943
Food & beverage: $943
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $194 |
| Alkermes, Inc. | 11 | $147 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $143 |
| Otsuka America Pharmaceutical, Inc. | 5 | $91 |
| Sage Therapeutics, LLC | 3 | $89 |
| Vanda Pharmaceuticals Inc. | 5 | $82 |
| E.R. Squibb & Sons, L.L.C. | 3 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Janssen Pharmaceuticals, Inc | 1 | $39 |
| Almatica Pharma LLC | 1 | $23 |
Products named: VRAYLAR, TRINTELLIX, REXULTI, ZURZUVAE, FANAPT, LYBALVI, ARISTADA, COBENFY.
Industry payments across OH — which companies pay providers there.
